| # | Drug | Count |
|---|---|---|
| 0 | AFLIBERCEPT | 479 |
| 1 | BROLUCIZUMAB | 358 |
| 2 | FARICIMAB | 269 |
| 3 | RANIBIZUMAB | 139 |
| 4 | BEVACIZUMAB | 138 |
| 5 | PREDNISONE | 80 |
| 6 | PEGCETACOPLAN | 75 |
| 7 | DEXAMETHASONE | 71 |
| 8 | METHOTREXATE SODIUM | 71 |
| 9 | POVIDONE-IODINE | 69 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENYLEPHRINE AND KETOROLAC | 4 | 0.0488 |
| 1 | PEGCETACOPLAN | 75 | 0.0395 |
| 2 | AVACINCAPTAD PEGOL | 13 | 0.0369 |
| 3 | BALANCED SALT SOLUTION | 44 | 0.0340 |
| 4 | FARICIMAB | 269 | 0.0303 |
| 5 | TETRACAINE HCL | 1 | 0.0286 |
| 6 | PROPARACAINE HYDROCHLORIDE | 15 | 0.0281 |
| 7 | RANIBIZUMAB-NUNA | 1 | 0.0213 |
| 8 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 7 | 0.0191 |
| 9 | RANIBIZUMAB-EQRN | 3 | 0.0185 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 700 |
| 1 | Corticosteroid [EPC] | 263 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 97 |
| 3 | Complement Inhibitor [EPC] | 75 |
| 4 | Antiseptic [EPC] | 69 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 62 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 49 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 47 |
| 8 | Aminoglycoside Antibacterial [EPC] | 46 |
| 9 | Anticholinergic [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cyclooxygenase Inhibitor [EPC] | 4 | 0.0488 |
| 1 | Antiseptic [EPC] | 69 | 0.0158 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 700 | 0.0038 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 13 | 0.0029 |
| 4 | Anticholinergic [EPC] | 40 | 0.0025 |
| 5 | Rifamycin Antimycobacterial [EPC] | 7 | 0.0020 |
| 6 | Quinolone Antimicrobial [EPC] | 17 | 0.0017 |
| 7 | Complement Inhibitor [EPC] | 75 | 0.0013 |
| 8 | Plasma Volume Expander [EPC] | 4 | 0.0013 |
| 9 | Aminoglycoside Antibacterial [EPC] | 46 | 0.0010 |